AT348535B - PROCESS FOR THE PRODUCTION OF NEW 1,2-DITHIOL DERIVATIVES - Google Patents

PROCESS FOR THE PRODUCTION OF NEW 1,2-DITHIOL DERIVATIVES

Info

Publication number
AT348535B
AT348535B AT90277A AT90277A AT348535B AT 348535 B AT348535 B AT 348535B AT 90277 A AT90277 A AT 90277A AT 90277 A AT90277 A AT 90277A AT 348535 B AT348535 B AT 348535B
Authority
AT
Austria
Prior art keywords
new
production
dithiol derivatives
dithiol
derivatives
Prior art date
Application number
AT90277A
Other languages
German (de)
Other versions
ATA90277A (en
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7603604A external-priority patent/FR2340730A1/en
Priority claimed from FR7638901A external-priority patent/FR2374906A2/en
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of ATA90277A publication Critical patent/ATA90277A/en
Application granted granted Critical
Publication of AT348535B publication Critical patent/AT348535B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/38One sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT90277A 1976-02-10 1977-02-10 PROCESS FOR THE PRODUCTION OF NEW 1,2-DITHIOL DERIVATIVES AT348535B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7603604A FR2340730A1 (en) 1976-02-10 1976-02-10 Heterocyclic (1,2)-dithiole-(3)-thione derivs. - for treatment of bilharziasis (BE 9.8.77)
FR7638901A FR2374906A2 (en) 1976-12-23 1976-12-23 Heterocyclic (1,2)-dithiole-(3)-thione derivs. - for treatment of bilharziasis (BE 9.8.77)

Publications (2)

Publication Number Publication Date
ATA90277A ATA90277A (en) 1978-07-15
AT348535B true AT348535B (en) 1979-02-26

Family

ID=26219294

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90277A AT348535B (en) 1976-02-10 1977-02-10 PROCESS FOR THE PRODUCTION OF NEW 1,2-DITHIOL DERIVATIVES

Country Status (26)

Country Link
US (1) US4110450A (en)
JP (1) JPS5822119B2 (en)
AR (1) AR224095A1 (en)
AT (1) AT348535B (en)
AU (1) AU509092B2 (en)
CA (1) CA1073906A (en)
CH (2) CH618699A5 (en)
DE (1) DE2705641C3 (en)
DK (1) DK55477A (en)
EG (1) EG13739A (en)
ES (3) ES455790A1 (en)
GB (1) GB1518071A (en)
HK (1) HK17481A (en)
HU (1) HU172528B (en)
IE (1) IE44561B1 (en)
IL (1) IL51403A (en)
KE (1) KE3126A (en)
LU (1) LU76728A1 (en)
MY (1) MY8200001A (en)
NL (1) NL171985C (en)
OA (1) OA05565A (en)
PH (1) PH12367A (en)
PT (1) PT66175B (en)
SE (1) SE427274B (en)
SU (1) SU683622A3 (en)
ZM (1) ZM1477A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
ATE491689T1 (en) * 1997-10-27 2011-01-15 Neurosearch As HETEROARYL DIAZACYCLOALKANES AS CHOLINERGIC LIGANDS FOR NICOTINE-ACETYLCHOLINE RECEPTORS
WO2001085142A1 (en) 2000-05-05 2001-11-15 Wisconsin Alumni Research Foundation Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
KR100491318B1 (en) * 2002-11-26 2005-05-24 씨제이 주식회사 Method for preparing oltipraz
EP1799668A1 (en) 2004-09-20 2007-06-27 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase
JP4958786B2 (en) 2004-09-20 2012-06-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド Heterocyclic derivatives and their use as therapeutic agents
US7592343B2 (en) 2004-09-20 2009-09-22 Xenon Pharmaceuticals Inc. Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
WO2006034341A2 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
US8071603B2 (en) 2004-09-20 2011-12-06 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CA2580787A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
BRPI0515488A (en) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc heterocyclic derivatives and their use as therapeutic agents
BRPI0611187A2 (en) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc amino thiazide derivatives as inhibitors of human stearoyl coa desaturase
US7910600B2 (en) * 2007-08-31 2011-03-22 Cylene Pharmaceuticals, Inc. Therapeutic kinase modulators
WO2016207914A2 (en) * 2015-06-25 2016-12-29 St Ip Holding Ag Methods for preparing oltipraz
US20160376259A1 (en) * 2015-06-25 2016-12-29 St Ip Holding Ag Methods for Preparing Oltipraz
WO2018047002A1 (en) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
WO2018047013A1 (en) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same
EP3762104A2 (en) 2018-03-07 2021-01-13 ST IP Holding AG Combination compositions and therapies comprising 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, and methods of making and using same
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1526768A (en) 1963-01-16 1968-05-31 Process for the preparation of sulfonic derivatives of dithiole-1, 2-thiones-3 variously substituted, and applications of the products thus obtained

Also Published As

Publication number Publication date
PT66175B (en) 1978-07-10
AU2213877A (en) 1978-08-17
PT66175A (en) 1977-03-01
GB1518071A (en) 1978-07-19
DE2705641B2 (en) 1980-05-08
IL51403A (en) 1980-09-16
DE2705641A1 (en) 1977-08-11
ES458688A1 (en) 1978-07-16
HK17481A (en) 1981-05-08
IE44561L (en) 1977-08-10
NL171985C (en) 1983-06-16
IE44561B1 (en) 1982-01-13
JPS5822119B2 (en) 1983-05-06
OA05565A (en) 1981-04-30
SE427274B (en) 1983-03-21
ES455790A1 (en) 1978-01-16
DK55477A (en) 1977-08-11
SU683622A3 (en) 1979-08-30
ATA90277A (en) 1978-07-15
LU76728A1 (en) 1977-08-18
AU509092B2 (en) 1980-04-17
NL7701107A (en) 1977-08-12
US4110450A (en) 1978-08-29
ZM1477A1 (en) 1977-12-21
AR224095A1 (en) 1981-10-30
IL51403A0 (en) 1977-04-29
EG13739A (en) 1983-03-31
HU172528B (en) 1978-09-28
PH12367A (en) 1979-01-29
JPS52113982A (en) 1977-09-24
CH619463A5 (en) 1980-09-30
SE7701460L (en) 1977-08-11
MY8200001A (en) 1982-12-31
DE2705641C3 (en) 1981-01-22
KE3126A (en) 1981-05-29
CH618699A5 (en) 1980-08-15
ES458689A1 (en) 1978-07-16
CA1073906A (en) 1980-03-18

Similar Documents

Publication Publication Date Title
AT353783B (en) PROCESS FOR THE PRODUCTION OF NEW PYRROLIDIN- 2-ON DERIVATIVES
ATA348877A (en) PROCESS FOR THE PRODUCTION OF NEW N-ACYLATES
AT348535B (en) PROCESS FOR THE PRODUCTION OF NEW 1,2-DITHIOL DERIVATIVES
AT349634B (en) PROCESS FOR THE PRODUCTION OF NEW ANTHRACYCLING LYCOSIDES
ATA918577A (en) PROCESS FOR THE PRODUCTION OF NEW AMINOSUGAR DERIVATIVES INHIBITING ALFA- GLUCOSIDASES
AT349028B (en) PROCESS FOR THE PRODUCTION OF NEW 1,2-DITHIOL DERIVATIVES
ATA448177A (en) PROCESS FOR THE PRODUCTION OF NEW DIPEPTIDE DERIVATIVES
AT350722B (en) PROCESS FOR THE PRODUCTION OF NEW KANAMYCIN DERIVATIVES
AT352875B (en) PROCESS FOR THE PREPARATION OF NEW 4-OXA-1-AZABICYCLO- (3,2,0) HEPTAN-7-OON DERIVATIVES
AT352279B (en) PROCESS FOR THE PRODUCTION OF NEW RIFAMYCINE COMPOUNDS
ATA432877A (en) PROCESS FOR THE PRODUCTION OF NEW DIPEPTIDE DERIVATIVES
AT350560B (en) PROCESS FOR THE PRODUCTION OF NEW INDAZOLYL- (4) -OXY-PROPANOLAMINES
AT357693B (en) METHOD FOR THE PRODUCTION OF NEW ERGOLEN DERIVATIVES
AT347457B (en) PROCESS FOR THE PRODUCTION OF NEW INDOLINOSPIROPYRANE COMPOUNDS
AT358577B (en) PROCESS FOR THE PRODUCTION OF NEW 1-ACYL-4-HYDROXY-IMIDAZOL-5-CARBOXAMIDE DERIVATIVES
AT347454B (en) PROCESS FOR THE PRODUCTION OF NEW 1,2,4-TRIAZOLYL DERIVATIVES
ATA664176A (en) PROCESS FOR THE PRODUCTION OF NEW N-ALKYL -2,4-DINITRO-6-TRIFLUOROMETHYLDIPHENYLAMINES
AT352280B (en) PROCESS FOR THE PRODUCTION OF NEW RIFAMYCINE COMPOUNDS
AT353411B (en) PROCESS FOR THE PRODUCTION OF NEW 4-DEDIMETHYLAMINO-4-ARYLSULFONAMIDO-5A, 6- -ANHYDROTETRACYCLINES
AT351018B (en) PROCESS FOR THE PRODUCTION OF NEW OPTICALLY ACTIVE DERIVATIVES OF D-THREO-1-PHENYL-2- TRIFLUOROACETAMIDOPROPANDIOL- (1,3)
AT353278B (en) PROCESS FOR THE PRODUCTION OF NEW AZETIDE DERIVATIVES
ATA153578A (en) PROCESS FOR THE PRODUCTION OF NEW 1,2-DITHIOL DERIVATIVES
AT347939B (en) PROCESS FOR THE PRODUCTION OF NEW, SUBSTITUTE 1,2,4-OXADIAZOLIDIN-3-ON COMPOUNDS
AT351558B (en) PROCESS FOR THE PRODUCTION OF NEW 2-FORMYL-AMINO-PHENYLGUANIDINES
AT352116B (en) PROCESS FOR THE PRODUCTION OF NEW 1,4-DIPHENYLPYRAZOLE DERIVATIVES

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee